NGL Fine Chem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE887E01022
  • NSEID: NGLFINE
  • BSEID: 524774
INR
2,766.15
-19.7 (-0.71%)
BSENSE

Nov 20

BSE+NSE Vol: 14.97 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Venus Remedies
NGL Fine Chem
Anlon Healthcare
Bharat Parenter.
Windlas Biotech
Beta Drugs Ltd
Jagsonpal Pharma
Amrutanjan Healt
Hester Bios
Dishman Carbogen
Accent Microcell
Why is NGL Fine Chem Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.07 times
2
Poor long term growth as Operating profit has grown by an annual rate -0.62% of over the last 5 years
3
With a growth in Net Profit of 68.74%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 4 consecutive quarters
  • OPERATING CF(Y) Highest at Rs 34.73 Cr
  • ROCE(HY) Highest at 18.13%
  • PAT(Q) At Rs 16.25 cr has Grown at 68.7%
4
Stock is technically in a Mildly Bullish range
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
5
With ROCE of 16.4, it has a Fair valuation with a 4 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 98.47%, its profits have risen by 208.5% ; the PEG ratio of the company is 0.1
6
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to NGL Fine Chem should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is NGL Fine Chem for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
NGL Fine Chem
98.47%
1.59
61.95%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.98%
EBIT Growth (5y)
-0.62%
EBIT to Interest (avg)
17.74
Debt to EBITDA (avg)
1.16
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
1.16
Tax Ratio
24.53%
Dividend Payout Ratio
5.12%
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
14.56%
ROE (avg)
12.86%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
27
Industry P/E
40
Price to Book Value
4.71
EV to EBIT
24.50
EV to EBITDA
18.83
EV to Capital Employed
4.02
EV to Sales
3.11
PEG Ratio
0.13
Dividend Yield
0.06%
ROCE (Latest)
16.41%
ROE (Latest)
17.60%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

29What is working for the Company
OPERATING CF(Y)

Highest at Rs 34.73 Cr

ROCE(HY)

Highest at 18.13%

PAT(Q)

At Rs 16.25 cr has Grown at 68.7%

NET SALES(Q)

Highest at Rs 158.71 cr

PBDIT(Q)

Highest at Rs 28.07 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 17.69%

PBT LESS OI(Q)

Highest at Rs 20.40 cr.

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for NGL Fine Chem
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 20.40 cr has Grown at 86.98%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Operating Cash Flow - Annually
Highest at Rs 34.73 Cr and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 16.25 cr has Grown at 68.7%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 158.71 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 158.71 cr has Grown at 31.97%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 28.07 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 17.69%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 20.40 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)